CVD risk prediction method with Microsoft (UK Biobank)
Clinical development Type not stated
Disclosed: Verified: Partners: Microsoft
An interpretable machine-learning method developed with Microsoft on UK Biobank data to predict atherosclerosis risk and flag new targets and biomarkers.